Effectiveness of nirsevimab immunoprophylaxis administered at birth to prevent infant hospitalisation for respiratory syncytial virus infection: a population-based cohort study - Ezpeleta, G; Navascués, A; Viguria, N (Vaccines (Basel), 2024)